Open access · US-GOV via ClinicalTrials.gov Clinical trial

Oral Microbiota and Muscle Function in the Ageing Subject: MYOBIOTA Study

Authors not listed

University Hospital, Rouen · 2026

Dysbiosis Human Randomized controlled trial

Abstract

Ageing of the general population may be a risk factor for various complications, including sarcopenia. Sarcopenia is a progressive loss of muscle mass and muscle strength, leading to a decrease in functional capacities. It affects between 0.7% and 16% of European adults over 70 years of age (1). Recent studies suggest that the faecal microbiota may be altered with ageing but also according to sarcopenic status. Furthermore, no study has currently published data on the relationship between salivary microbiota and sarcopenic status. The main hypothesis of this study is that a decrease in salivary microbiota richness could be associated with impaired handgrip strength in the ageing subject.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-17 MST

Cite this

APA

Anonymous. (2026). Oral Microbiota and Muscle Function in the Ageing Subject: MYOBIOTA Study. <em>University Hospital, Rouen</em>. https://clinicaltrials.gov/study/NCT07687511

Vancouver

Anonymous. Oral Microbiota and Muscle Function in the Ageing Subject: MYOBIOTA Study. University Hospital, Rouen. 2026.

BibTeX

@misc{anon2026OralMi, title = {Oral Microbiota and Muscle Function in the Ageing Subject: MYOBIOTA Study}, author = {Anonymous}, journal = {University Hospital, Rouen}, year = {2026}, }